• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RB 通路改变伴 RB1 失活特征性表现为具有原始神经成分的胶质母细胞瘤。

Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.

机构信息

From the Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

J Neuropathol Exp Neurol. 2021 Dec 29;80(12):1092-1098. doi: 10.1093/jnen/nlab109.

DOI:10.1093/jnen/nlab109
PMID:34850045
Abstract

A primitive neuronal component is a feature of some glioblastomas but defining molecular alterations of this histologic variant remains uncertain. We performed next-generation sequencing of 1500 tumor related genes on tissue from 9 patients with glioblastoma with a primitive component (G/PN) and analyzed 27 similar cases from the Cancer Genome Atlas (TCGA) dataset. Alterations in the RB pathway were identified in all of our patients' tumors and 81% of TCGA tumors with the retinoblastoma tumor suppressor gene (RB1) commonly affected. Although RB1 mutations were observed in some conventional glioblastomas, the allelic fractions of these mutations were significantly higher in tumors with a primitive neuronal component in both our and TCGA cohorts (median, 72% vs 25%, p < 0.001 and 80% vs 40%, p < 0.02, respectively). Further, in 78% of patients in our cohort, RB expression was lost by immunohistochemistry. Our findings indicate that alterations in the RB pathway are common in G/PNs and suggest that inactivation of RB1 may be a driving mechanism for the phenotype.

摘要

原始神经成分是某些胶质母细胞瘤的特征,但这种组织学变异的分子改变仍不确定。我们对 9 例具有原始成分(G/PN)的胶质母细胞瘤患者的组织进行了 1500 个肿瘤相关基因的下一代测序,并分析了癌症基因组图谱(TCGA)数据集的 27 个类似病例。我们所有患者的肿瘤中都发现了 RB 通路的改变,并且 RB1 视网膜母细胞瘤肿瘤抑制基因常见受影响,占 81%的 TCGA 肿瘤。虽然在一些常规胶质母细胞瘤中观察到 RB1 突变,但在我们和 TCGA 队列中具有原始神经元成分的肿瘤中,这些突变的等位基因分数明显更高(中位数,分别为 72%比 25%,p<0.001 和 80%比 40%,p<0.02)。此外,在我们队列中的 78%的患者中,免疫组化检测到 RB 表达缺失。我们的研究结果表明,RB 通路的改变在 G/PN 中很常见,并表明 RB1 的失活可能是该表型的驱动机制。

相似文献

1
Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.RB 通路改变伴 RB1 失活特征性表现为具有原始神经成分的胶质母细胞瘤。
J Neuropathol Exp Neurol. 2021 Dec 29;80(12):1092-1098. doi: 10.1093/jnen/nlab109.
2
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.具有原始神经元成分的胶质母细胞瘤具有独特的甲基化和拷贝数谱,同时存在 TP53、PTEN 和 RB1 的失活。
Acta Neuropathol. 2021 Jul;142(1):179-189. doi: 10.1007/s00401-021-02302-6. Epub 2021 Apr 19.
3
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.伴有至少 30%巨细胞的 IDH 野生型胶质母细胞瘤的特征是频繁的 RB1 和 NF1 改变和高度突变。
Acta Neuropathol Commun. 2021 Dec 24;9(1):200. doi: 10.1186/s40478-021-01304-5.
4
Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.一名患有散发、孤立、颅内、鞍区视网膜母细胞瘤的婴儿,其 RB1 基因座发生复杂结构重排的分子分类。
Acta Neuropathol Commun. 2021 Apr 7;9(1):61. doi: 10.1186/s40478-021-01164-z.
5
Spectrum of germline mutations and clinical manifestations in retinoblastoma patients from Thailand.泰国视网膜母细胞瘤患者的胚系突变谱及临床表现
Mol Vis. 2018 Dec 9;24:778-788. eCollection 2018.
6
Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.基于视网膜母细胞瘤肿瘤抑制蛋白 (RB1) 改变的胶质母细胞瘤临床分层与前体细胞亚型的相关性。
J Neuropathol Exp Neurol. 2012 Jan;71(1):83-9. doi: 10.1097/NEN.0b013e31823fe8f1.
7
RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma.胶质母细胞瘤中 RB1 启动子甲基化:胶质母细胞瘤中的罕见事件。
Oncol Rep. 2023 Jul;50(1). doi: 10.3892/or.2023.8580. Epub 2023 Jun 2.
8
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.视网膜母细胞瘤的下一代测序鉴定了除 RB1 失活之外与侵袭性组织病理学特征相关的致病性改变。
Ophthalmology. 2020 Jun;127(6):804-813. doi: 10.1016/j.ophtha.2019.12.005. Epub 2019 Dec 12.
9
Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.pRb的磷酸化:MYCN扩增的视网膜母细胞瘤中RB通路失活的机制
Cancer Med. 2017 Mar;6(3):619-630. doi: 10.1002/cam4.1010. Epub 2017 Feb 17.
10
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.RB1 和 TP53 共突变与膀胱癌对免疫检查点抑制剂反应的基因组生物标志物密切相关。
BMC Cancer. 2021 Apr 20;21(1):432. doi: 10.1186/s12885-021-08078-y.

引用本文的文献

1
EGFR alteration is an adverse prognostic factor in IDH-mutant astrocytoma.表皮生长因子受体(EGFR)改变是异柠檬酸脱氢酶(IDH)突变型星形细胞瘤的不良预后因素。
Acta Neuropathol. 2025 Aug 19;150(1):20. doi: 10.1007/s00401-025-02928-w.
2
Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022-2025).大麻素治疗神经胶质瘤的潜在进展:系统综述(2022 - 2025年)
Pharmacol Res Perspect. 2025 Aug;13(4):e70160. doi: 10.1002/prp2.70160.
3
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes.
囊性胶质母细胞瘤IDH野生型:基因改变与预后
J Neurooncol. 2025 Jul 3. doi: 10.1007/s11060-025-05143-5.
4
ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital.在缺乏H3改变或异柠檬酸脱氢酶(IDH)突变的成人胶质瘤中ATRX缺失:特殊诊断的特殊情况——圣安妮医院的经验
Acta Neuropathol Commun. 2025 Jun 13;13(1):131. doi: 10.1186/s40478-025-02044-6.
5
Rare glioblastoma subtype masquerading as a poorly differentiated carcinoma: illustrative case.伪装成低分化癌的罕见胶质母细胞瘤亚型:病例说明
J Neurosurg Case Lessons. 2025 Mar 10;9(10). doi: 10.3171/CASE24553.
6
Targeting TUBG1 in RB1-negative tumors.针对RB1阴性肿瘤中的TUBG1
FASEB J. 2025 Mar 15;39(5):e70431. doi: 10.1096/fj.202403180RR.
7
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription.RB1和P53通路的同时破坏会促使高级别胶质瘤中原始神经元成分的发展,这取决于MYC驱动的EBF3转录。
Acta Neuropathol. 2025 Jan 16;149(1):8. doi: 10.1007/s00401-025-02845-y.
8
Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma.胶质肉瘤的分子特征揭示了预后生物标志物以及与胶质母细胞瘤的临床相似之处。
J Neurooncol. 2025 Jan;171(2):403-411. doi: 10.1007/s11060-024-04859-0. Epub 2024 Oct 30.
9
On the Boundary of Exploratory Genomics and Translation in Sequential Glioblastoma.序贯胶质母细胞瘤中的探索性基因组学与转化的边界
Int J Mol Sci. 2024 Jul 10;25(14):7564. doi: 10.3390/ijms25147564.
10
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.胶质母细胞瘤:病理学、分子机制和生物标志物的最新研究进展。
Int J Mol Sci. 2024 Mar 6;25(5):3040. doi: 10.3390/ijms25053040.